European equities closed mixed on Friday after a choppy end to trading in July, as investors eyed key earnings.» Read More
Lindsey Piegza, chief economist at Stifel Fixed Income, discusses U.S. GDP growth in the second quarter and when the Federal Reserve will raise interest rates.
David Bloom, global head of foreign exchange strategy at HSBC, discusses the euro/dollar and when the Federal Reserve may raise interest rates.
European stocks finished higher on Wednesday after a bumper day of earnings.
Zsolt Papp, global head of emerging market debt portfolio strategies at JPMorgan Asset Management, discusses how emerging markets might react to an interest rate hike by the Federal Reserve.
Daragh Maher, FX strategist at HSBC, discusses when the Federal Reserve might raise interest rates.
Andrew Parry, head of equities at Hermes, discusses the earnings trend in European companies emerging this quarter.
David Wild, CEO of Domino's Pizza Group PLC, talks about getting involved in mobile tech, greater transparency on nutrition and expanding in Europe.
Joseph Dayan, head of markets at BCS Financial Group, explains why he thinks Russia's central bank will "pause and wait" when it comes to cutting interest rates.
European equities ended in positive territory on Tuesday, as investors kept an eye on the slew of earnings and the start of the Federal Reserve meeting.
Michael Hulme, commodity equities fund manager at Carmignac, talks about BP's future following its Q2 earnings.
Bob Parker, senior advisor of investment strategy & research at Credit Suisse, lays out expectations on how the U.S. Federal Reserve will hike rates over the next 18 months.
Kawther Hashem, nutritionist and researcher for "Action on Sugar," explains why transparent labeling on sugary foods should be more widely used in U.K. supermarkets.
Teva Pharmaceutical has announced plans to acquire Allergan's generic drug business for $40.5 billion. Ronny Gal, stock analyst at Sanford C. Bernstein, discusses.
European stock closed lower on Monday, after a sharp selloff in Asian shares highlighted concerns about Chinese market volatility and slowing growth.
On Monday, the Shanghai Composite had its biggest one-day drop since Feb 2007, yet Douglas Morton, head of Asia research at Aviate Global, explains why the moves aren't that extraordinary.
Suki Virji, analyst for Scrip Intelligence, discusses the malaria vaccine developed by GlaxoSmithKline, which has received a "green light" by the European Medicines Agency.
European stocks finished off the week in the red, following a volatile five days of mixed earnings and a sell-off in commodities.
Marc Elliott, mining analyst at Investec, discusses the job cuts at Lonmin and other mining companies, as commodity prices, hit record lows.
David Stubbs, global markets strategist at J.P. Morgan Asset Management, explains why equities across Europe have fallen.
Martin Deboo, senior vice president at Jefferies, explains why his company upgraded Unilever's rating and talks about who might be their next CEO.